Alan Reynolds

1.7k total citations
37 papers, 1.3k citations indexed

About

Alan Reynolds is a scholar working on Rheumatology, Molecular Biology and Insect Science. According to data from OpenAlex, Alan Reynolds has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 7 papers in Molecular Biology and 7 papers in Insect Science. Recurrent topics in Alan Reynolds's work include Rheumatoid Arthritis Research and Therapies (8 papers), Antibiotic Resistance in Bacteria (6 papers) and Insect-Plant Interactions and Control (5 papers). Alan Reynolds is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Antibiotic Resistance in Bacteria (6 papers) and Insect-Plant Interactions and Control (5 papers). Alan Reynolds collaborates with scholars based in United Kingdom, United States and Spain. Alan Reynolds's co-authors include Fred Gould, William J. Moar, J. M. T. Hamilton‐Miller, Paul Emery, W. Brumfitt, Xavier Mariette, Ronald J. Prokopy, Marco Matucci‐Cerinic, Ceara AE Walsh and Richard Lawson and has published in prestigious journals such as The Lancet, Journal of Agricultural and Food Chemistry and The Journal of Infectious Diseases.

In The Last Decade

Alan Reynolds

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan Reynolds United Kingdom	18	355	337	299	244	181	37	1.3k
Yael Levy Israel	22	288 0.8×	174 0.5×	209 0.7×	703 2.9×	40 0.2×	86	1.7k
Batia Weiss Israel	28	403 1.1×	138 0.4×	88 0.3×	837 3.4×	53 0.3×	99	3.0k
Yi‐Hsing Chen Taiwan	22	491 1.4×	186 0.6×	19 0.1×	26 0.1×	25 0.1×	72	1.5k
J. Quiralte Spain	28	233 0.7×	278 0.8×	44 0.1×	98 0.4×	404 2.2×	84	2.6k
Jörg Kleine‐Tebbe Germany	36	282 0.8×	229 0.7×	91 0.3×	59 0.2×	128 0.7×	202	4.8k
A. Neuer United States	17	313 0.9×	64 0.2×	46 0.2×	23 0.1×	68 0.4×	34	906
Vanessa Carregaro Brazil	22	338 1.0×	98 0.3×	56 0.2×	27 0.1×	47 0.3×	44	1.5k
Sudhanshu Bhushan Germany	26	421 1.2×	91 0.3×	16 0.1×	33 0.1×	25 0.1×	59	1.9k
Bernadette Eberlein Germany	25	125 0.4×	176 0.5×	100 0.3×	45 0.2×	411 2.3×	94	2.0k
C. André France	32	274 0.8×	91 0.3×	32 0.1×	39 0.2×	36 0.2×	120	4.2k

Countries citing papers authored by Alan Reynolds

Since Specialization

Citations

This map shows the geographic impact of Alan Reynolds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Reynolds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Reynolds more than expected).

Fields of papers citing papers by Alan Reynolds

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Reynolds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Reynolds. The network helps show where Alan Reynolds may publish in the future.

Co-authorship network of co-authors of Alan Reynolds

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Reynolds. A scholar is included among the top collaborators of Alan Reynolds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Reynolds. Alan Reynolds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fernández-Moreno, M., et al.. (2025). APPA SHOWED SENOLYTIC CAPACITY IN SENESCENT CHONDROCYTES. Osteoarthritis and Cartilage. 33. S330–S331. 1 indexed citations

Bihlet, Asger Reinstrup, I. Byrjalsen, J.R. Andersen, et al.. (2024). The efficacy and safety of a fixed-dose combination of apocynin and paeonol, APPA, in symptomatic knee OA: A double-blind, randomized, placebo-controlled, clinical trial. Osteoarthritis and Cartilage. 32(7). 952–962. 7 indexed citations

Fernández-Moreno, M., et al.. (2024). Anti-Inflammatory Activity of APPA (Apocynin and Paeonol) in Human Articular Chondrocytes. Pharmaceuticals. 17(1). 118–118. 2 indexed citations

Bannister, Christian, James Orr, Alan Reynolds, et al.. (2016). Natural History of Patients Taking Rifaximin-α for Recurrent Hepatic Encephalopathy and Risk of Future Overt Episodes and Mortality: A Post-hoc Analysis of Clinical Trials Data. Clinical Therapeutics. 38(5). 1081–1089.e4. 16 indexed citations

Prokopy, Ronald J., et al.. (2013). Can Rhagoletis pomonella flies (Diptera: Tephritidae) learn to associate presence of food on foliage with foliage color?. European Journal of Entomology. 95(3). 335–341. 1 indexed citations

Morgan, Christopher Ll., Paul Emery, Duncan Porter, et al.. (2013). Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational data. Lara D. Veeken. 53(1). 186–194. 53 indexed citations

Reynolds, Alan, Andrew Koenig, Eustratios Bananis, & Amitabh Singh. (2012). When is switching warranted among biologic therapies in rheumatoid arthritis?. Expert Review of Pharmacoeconomics & Outcomes Research. 12(3). 319–333. 30 indexed citations

Mariette, Xavier, Alan Reynolds, & Paul Emery. (2012). Updated meta-analysis of non-melanoma skin cancer rates reported from prospective observational studies in patients treated with tumour necrosis factor inhibitors. Annals of the Rheumatic Diseases. 71(12). e2–e2. 19 indexed citations

Mariette, Xavier, Marco Matucci‐Cerinic, Karel Pavelká, et al.. (2011). Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis. Annals of the Rheumatic Diseases. 70(11). 1895–1904. 306 indexed citations

10.

Moots, Robert J., Andrew J.K. Östör, Anne Gitte Loft, et al.. (2011). Reduction of direct and indirect costs in patients with AS receiving etanercept: results from an open-label 36-week extension of the ASCEND study in four European countries. Lara D. Veeken. 51(2). 393–396. 6 indexed citations

11.

Poole, Chris D., Pete Conway, Alan Reynolds, & Craig J. Currie. (2008). The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study. BMC Musculoskeletal Disorders. 9(1). 146–146. 10 indexed citations

12.

Lloyd, Amanda Abramson, et al.. (2008). Economic evaluation of etanercept in the management of chronic plaque psoriasis. British Journal of Dermatology. 160(2). 380–386. 21 indexed citations

13.

Ara, Roberta, et al.. (2007). The cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in the UK. Lara D. Veeken. 46(8). 1338–1344. 31 indexed citations

14.

Bansback, Nick, Roberta Ara, Alan Brennan, et al.. (2006). Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis. Lara D. Veeken. 45(8). 1029–1038. 39 indexed citations

15.

Lenox‐Smith, Alan & Alan Reynolds. (2003). A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care.. PubMed. 53(495). 772–7. 44 indexed citations

16.

Malizia, Andrea L., Jan Melichar, Christopher G. Rhodes, et al.. (2000). Desipramine binding to noradrenaline reuptake sites in cardiac sympathetic neurons in man in vivo. European Journal of Pharmacology. 391(3). 263–267. 11 indexed citations

17.

Hamilton-Miller, J M, et al.. (1978). Cefotaxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro. Journal of Antimicrobial Chemotherapy. 4(5). 437–444. 79 indexed citations

18.

Reynolds, Alan, J. M. T. Hamilton‐Miller, & W. Brumfitt. (1975). A comparison of the in vitro activity of metronidazole, tinidazole, and nimorazole against Gram-negative anaerobic bacilli.. Journal of Clinical Pathology. 28(10). 775–778. 21 indexed citations

19.

Brumfitt, W., Alan Reynolds, & J. M. T. Hamilton‐Miller. (1975). ACTIVITY OF NITROFURANTOIN AND NIFURATEL AGAINST ANAEROBIC GRAM-NEGATIVE BACILLI. The Lancet. 305(7904). 460–460. 5 indexed citations

20.

Reynolds, Alan, J. M. T. Hamilton‐Miller, & W. Brumfitt. (1974). Newer Aminoglycosides—Amikacin and Tobramycin: An in-vitro Comparison with Kanamycin and Gentamicin. BMJ. 3(5934). 778–780. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact